THE FREQUENCY OF OCCURRENCE OF SECONDARY MALIGNANT TUMORS EVOLVING ON THE FIELD OF PRIMARY BREAST CANCER IN THE FEMALE POPULATION OF HUNGARY BETWEEN 2003 AND 2007

Author(s)

Imre Boncz, MD, MSc, PhD, Associate Professor And Department Head1, Levente Gazdag, BSc, MSc, PhD student1, Jakab Eszter Farkasné, MSc, PhD student1, József Bódis, MD, PhD, DSc, Professor and Dean2, Katalin Németh, MSc, Lecturer1, László Kornya, MD, PhD student1, Ildikó Vránics, MSc, PhD student1, Krisztina Gabara, MSc, PhD student1, Ildikó Kriszbacher, MSc, PhD, Associate Professor21University of Pécs, Pécs, Hungary; 2 University of Pécs, Pecs, Hungary

OBJECTIVES The purpose of this study was to determine the frequency of occurrence of secondary tumors affecting other organs in case of patients suffering from tumor located in any fields of the breast. METHODS Data were collected from the financing database of the National Health Insurance Fund Administration (OEP). The subject of the observation aimed female patients treated in hospitals with primary breast tumor (BNO: C5000-C5090, D0570, D0590) between the period of January 1, 2002 and December 31, 2002. Accordingly we examined the frequency of occurrence of secondary tumors evolving after occurrence of the primary tumor in the following 5 years (2003-2007). RESULTS In 2002, a total of 10,378 patients (21,418 cases) were treated with malignant breast tumor. 2,870 primary breast tumor patients attended in hospitals with tumor disorders in any organs between 2003 and 2007. The first five malignant diseases appeared the most often in the examined period were: malignant tumors in the bones and bone marrow in 298 patients, malignant tumor in the lung in 212 patients, malignant tumor in the lymph gland in 186 cases, malignant tumor of the liver in 182 cases and malignant brain and dural tumor in 151 cases. The frequency of occurrence of these tumors projected on 10,000 primary breast tumors is the following: malignant tumors in the bones and bone marrow in 395 patients, malignant tumor in the lung in 281 patients, malignant tumor in the lymph gland in 246 cases, malignant tumor of the liver in 241 cases and malignant brain and dural tumor in 200 cases. CONCLUSIONS In the following 5 years of the primary breast tumor diseases other malignant tumors affecting other organs were evolved in 21.32% of the patients. In 26.67% of the patients no secondary tumors were evolved, but the primary tumor needed further treatment.

Conference/Value in Health Info

2009-05, ISPOR 2009, Orlando, FL, USA

Value in Health, Vol. 12, No. 3 (May 2009)

Code

PCN2

Topic

Epidemiology & Public Health

Disease

Oncology

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×